Oncology Central

Landmark study raises the bar for interventional oncology


The recent publication of the SIRFLOX trial in the Journal of Clinical Oncology [1] is a landmark for oncologists and radiologists involved in the rapidly advancing field of interventional oncology and liver-directed therapies. The findings are relevant to all oncologists who treat patients with liver metastases.

To view restricted content, please:



News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.